4//SEC Filing
Postma Robert W 4
Accession 0001209191-21-054825
CIK 0001107421other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:22 PM ET
Size
7.5 KB
Accession
0001209191-21-054825
Insider Transaction Report
Form 4
Postma Robert W
Director
Transactions
- Purchase
Common Stock
2021-09-02$1.73/sh+20,508$35,479→ 1,201,870 total - Purchase
Common Stock
2021-09-02$1.73/sh+54,492$94,271→ 4,250,000 total(indirect: See footnote)
Holdings
- 3,574(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock.
- [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001827847
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:22 PM ET
- Size
- 7.5 KB